Search

everythinglearnresearchcommunity

for

Search:↓

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

The interdigital gland of Vembur sheep shows sex-based differences in size and chemical makeup, possibly affecting communication and disease protection.

Zinc and copper levels may affect erectile dysfunction by influencing hormone levels.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

Cortisone in hair is a more reliable indicator of stress hormone exposure than cortisol.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Moving horses to new places can increase their stress levels, as shown by higher stress hormone in their hair.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

Drinking lots of sugary drinks may increase the risk of hair loss in young men.

Continuous use of hair relaxers and curlers can cause hair loss, dryness, dandruff, thinning, greying, and split ends.

Low selenium intake may delay puberty in boys but not in girls.

PCOS may be linked to spina bifida in young females.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

Testosterone affects brain behavior in complex and varied ways.

COVID-19 vaccines do not increase the risk of alopecia areata.

Hair greying is mainly influenced by age, with genetics playing a smaller role.

More body hair in young Australian women is linked to higher androstenedione levels.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.